NewAmsterdam Pharma Co N.V. - Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by NewAmsterdam Pharma Company N.V. covers the month of May 2023. The registrant is a foreign private issuer based in Naarden, The Netherlands. The filing serves to notify shareholders of the convening notice for the 2023 Annual General Meeting.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding a shareholder meeting and does not contain financial statements or performance data.
Material Changes
No material financial changes versus the prior comparable period are reported in this filing. The primary event is the scheduling of the Annual General Meeting.
Guidance, Outlook, and Management Commentary
The filing announces that the 2023 Annual General Meeting is expected to take place on June 20, 2023, at 4:00 p.m. CEST. The meeting will be held at the offices of NautaDutilh N.V. in Amsterdam, the Netherlands. A copy of the convening notice is included as Exhibit 99.1. No specific guidance, outlook, risks, or contingencies are detailed in this text.
Key Facts for Investor Verification
- Meeting Date: June 20, 2023.
- Meeting Time: 4:00 p.m. CEST.
- Meeting Location: NautaDutilh N.V., Beethovenstraat 400, 1082 PR Amsterdam, the Netherlands.
- Document Reference: Convening Notice is attached as Exhibit 99.1.
- Financial Data: None provided in this specific filing; investors should refer to the most recent Form 20-F or quarterly reports for financial metrics.